The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study
Abstract
Bronchiolitis obliterans syndrome remains the leading cause of morbidity and mortality in the pulmonary transplant population. Previous studies show that macrolide antibiotics may be efficacious in the treatment of panbronchiolitis and cystic fibrosis. In the latter, azithromycin decreases the number of respiratory exacerbations, improves FEV1, and improves quality of life. We hypothesized that oral azithromycin therapy may improve lung function in patients with bronchiolitis obliterans syndrome. To test this hypothesis, we conducted an open-label pilot trial using maintenance azithromycin therapy in six lung transplant recipients (250 mg orally three times per week for a mean of 13.7 weeks). In this study, five of these six individuals demonstrated significant improvement in pulmonary function, as assessed by FEV1, as compared with their baseline values at the start of azithromycin therapy. The mean increase in the percentage of predicted FEV1 values in these individuals was 17.1% (p </= 0.05). In addition, the absolute FEV1 increased by 0.50 L (range -0.18 to 1.36 L). These data suggest a potential role for maintenance macrolide therapy in the treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin
KUDOH, S., AZUMA, A., YAMAMOTO, M., IZUMI, T., & ANDO, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9710075 · Cited by 582
Wolter, J. (2002) · Thorax · doi:10.1136/thorax.57.3.212 · Cited by 518
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Anti-inflammatory activity of macrolide antibiotics
Michie, C. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02441-3 · Cited by 356
Mycoplasma pneumoniae and Chlamydia pneumoniae in Asthma
Kraft, M., Cassell, G. H., Pak, J., & Martin, R. J. (2002) · Chest · doi:10.1378/chest.121.6.1782 · Cited by 335
Anti-Inflammatory Activity of Macrolide Antibiotics
Ianaro, A., Ialenti, A., Maffia, P., Sautebin, L., Rombolà, L., Carnuccio, R., Iuvone, T., D’Acquisto, F., & Di Rosa, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35272-3 · Cited by 309
Long-term azithromycin may improve lung function in children with cystic fibrosis
Jaffé, A., Francis, J., Rosenthal, M., & Bush, A. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78360-4 · Cited by 276
THE EFFECT OF ANTIMICROBIAL AGENTS ON LEUKOCYTE CHEMOTAXIS
Esterly, N. B., Furey, N. L., & Flanagan, L. E. (1978) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12543487 · Cited by 254
Čulić, O., Eraković, V., Čepelak, I., Barišić, K., Brajša, K., Ferenčić, Ž., Galović, R., Glojnarić, I., Manojlović, Z., Munić, V., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02042-3 · Cited by 234
BLACK, P. N., BLASI, F., JENKINS, C. R., SCICCHITANO, R., MILLS, G. D., RUBINFELD, A. R., RUFFIN, R. E., MULLINS, P. R., DANGAIN, J., COOPER, B. C., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2011040 · Cited by 167
Cited by
Verleden, G. M., Glanville, A. R., Lease, E. D., Fisher, A. J., Calabrese, F., Corris, P. A., Ensor, C. R., Gottlieb, J., Hachem, R. R., Lama, V., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.03.009 · Cited by 952
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 708
Azithromycin: Mechanisms of action and their relevance for clinical applications
Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.003 · Cited by 661
Meyer, K. C., Raghu, G., Verleden, G. M., Corris, P. A., Aurora, P., Wilson, K. C., Brozek, J., Glanville, A. R., & the ISHLT/ATS/ERS BOS Task Force Committee (2014) · European Respiratory Journal · doi:10.1183/09031936.00107514 · Cited by 555
A new classification system for chronic lung allograft dysfunction
Verleden, G. M., Raghu, G., Meyer, K. C., Glanville, A. R., & Corris, P. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.10.022 · Cited by 503
Amsden, G. W. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh519 · Cited by 409
Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation
Kotloff, R. M., Ahya, V. N., & Crawford, S. W. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1322so · Cited by 365
Charlson, E. S., Diamond, J. M., Bittinger, K., Fitzgerald, A. S., Yadav, A., Haas, A. R., Bushman, F. D., & Collman, R. G. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0693oc · Cited by 348
Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
Rémy, B., Mion, S., Plener, L., Elias, M., Chabrière, E., & Daudé, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00203 · Cited by 332
Barker, A. F., Bergeron, A., Rom, W. N., & Hertz, M. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1204664 · Cited by 316
Zarogoulidis, P., Papanas, N., Kioumis, I., Chatzaki, E., Maltezos, E., & Zarogoulidis, K. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1161-x · Cited by 299
Verleden, G. M., Vanaudenaerde, B. M., Dupont, L. J., & Van Raemdonck, D. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200601-071oc · Cited by 296
Vos, R., Vanaudenaerde, B. M., Verleden, S. E., De Vleeschauwer, S. I., Willems-Widyastuti, A., Van Raemdonck, D. E., Schoonis, A., Nawrot, T. S., Dupont, L. J., & Verleden, G. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00068310 · Cited by 268
Metadata
- Authors
- Gerhardt, S. G., McDyer, J. F., Girgis, R. E., Conte, J. V., Yang, S. C., & Orens, J. B.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-07-01
- Volume
- 168
- Issue
- 1
- Pages
- 121-125
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2112046799
- Cited by
- 306
- References
- 22
- FWCI
- 20.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.